Activity of decitabine combined with all-<i>trans</i> retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER)

• Christoph Rummelt,
• Olga Grishina,
• Claudia Schmoor,
• Martina Crysandt,
• Michael Heuser,
• Katharina S. Götze,
• Richard F. Schlenk,
• Konstanze Döhner,
• Helmut R. Salih,
• Gerhard Heil,
• Carsten Müller-Tidow,
• Wolfram Brugger,
• Andrea Kündgen,
• Maike de Wit,
• Aristoteles Giagounidis,
• Sebastian Scholl,
• Andreas Neubauer,
• Jürgen Krauter,
• Gesine Bug,
• Haifa Kathrin Al-Ali,
• Ralph Wäsch,
• Heiko Becker,
• Annette M. May,
• Justus Duyster,
• Björn Hackanson,
• Arnold Ganser,
• Hartmut Döhner,
• Michael Lübbert

Affiliations

Christoph Rummelt

Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg

Olga Grishina

Clinical Trials Unit, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg

Claudia Schmoor

Clinical Trials Unit, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg

Martina Crysandt

Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen University, Aachen

Michael Heuser

Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover

Katharina S. Götze

Department of Medicine III, Technical University of Munich, Munich, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, München

Richard F. Schlenk

Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; National Center of Tumor Diseases, NCT-Trial Center, German Cancer Research Center, Heidelberg

Konstanze Döhner

Department of Internal Medicine III, University Hospital of Ulm, Ulm

Helmut R. Salih

Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tuebingen

Gerhard Heil

Department of Hematology/Oncology, Klinikum Luedenscheid, Luedenscheid

Carsten Müller-Tidow

Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Heidelberg, Heidelberg, Germany; Department of Medicine A, University Hospital of Münster, Münster

Wolfram Brugger

Department of Hematology, Hospital Villingen-Schwenningen, Villingen-Schwenningen

Andrea Kündgen

Department of Hematology, Oncology and Clinical Immunology, Heinrich- Heine-University, Faculty of Medicine, Düsseldorf, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Düsseldorf, Düsseldorf

Maike de Wit

Department of Hematology and Oncology, Vivantes Klinikum Neukölln, Berlin

Aristoteles Giagounidis

Clinic for Oncology, Hematology and Palliative Medicine, Marien-Hospital Düsseldorf, Düsseldorf

Sebastian Scholl

Department of Hematology and Oncology, Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena

Andreas Neubauer

Department of Hematology and Oncology, University Clinic Gießen/Marburg, Marburg

Jürgen Krauter

Department of Internal Medicine III, Städtisches Klinikum Braunschweig, Braunschweig

Gesine Bug

Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Frankfurt, Frankfurt

Haifa Kathrin Al-Ali

Krukenberg Cancer Center, University Hospital Halle, Halle

Ralph Wäsch

Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg

Heiko Becker

Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg

Annette M. May

Institute for Surgical Pathology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg

Justus Duyster

Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg

Björn Hackanson

Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Hematology/Oncology, Universitätsklinikum Augsburg, Augsburg

Arnold Ganser

Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover

Hartmut Döhner

Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg

Michael Lübbert

Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg